Hosted on MSN
Experts find 'more accurate way' of detecting prostate cancer - and it's easier than a blood test
A urine test for prostate cancer has proved to be far more accurate at detection than the current blood tests used. The new technique is now the ‘prime candidate’ for potential clinical trials, ...
President Joe Biden delivers remarks in the East Room of the White House in Washington, D.C., on June 4, 2024. President Joe Biden delivers remarks in the East Room of the White House in Washington, D ...
Former President Joe Biden is commenting publicly for the first time Monday after it was announced he was diagnosed with an "aggressive form" of prostate cancer. "Cancer touches us all. Like so many ...
Soy Nómada on MSN
5 early warning signs of prostate cancer men shouldn't ignore
Learn the five key warning signs of prostate cancer, from urinary issues to unexplained pain. Early detection is crucial for ...
A noticeably frail Joe Biden was seen in public Saturday for the first time since news broke that he is undergoing radiation therapy for prostate cancer — attending evening Mass at St. Joseph on the ...
Study links higher expression of the gene PROX1 to aggressive change in prostate tumor cells; FDA-approved class of drugs can disable PROX1 ANN ARBOR, Michigan — Researchers at the University of ...
Source: Getty Images To date, there is a lack of high-quality data comparing focal therapies to prostate cancer surgery or radiation. Focal therapy is emerging as a standard management strategy for ...
Researchers at the American University in Cairo found a 2,200-year-old mummy had prostate cancer, which suggests the disease is caused by genetics not environment, according to an Associated Press ...
The ARID II trial investigates the Voro Urologic Scaffold's safety and efficacy in prostate cancer patients undergoing robotic-assisted radical prostatectomy. The scaffold aims to improve urinary ...
Pocenbrodib is being tested alone and with Zytiga, Lynparza, or Pluvicto in metastatic castration-resistant prostate cancer patients. The trial aims to address resistance to androgen receptor-targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results